Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pooled human plasma vs crystalloid in fluid management of children undergoing spinal fusion for scoliosis
2024-514857-31-00Phase 2Authorised
- Sponsor
- Helsinki University Hospital
- Start
- Nov 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in neuromuscular scoliosis and adolescent idiopathic scoliosis (AIS) comparing Pooled human plasma (octaplasLG) with Balanced crystalloid (Plasma-Lyte 148) (2 arms). Primary endpoint: Intraoperative blood loss. Planned start Nov 2024; status: authorised.
02
Drugs
octaplas lgplasma-lyte
03
Conditions
neuromuscular scoliosisadolescent idiopathic scoliosis (AIS)
Beyond the preview
Go deeper on 2024-514857-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514857-31-00.